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abStract
Non-conventional endoprostheses (NCE) are frequently used 
in orthopedic oncology. The complications associated with this 
procedure have prompted research, due to the fact that it is 
commonly performed on young patients, with a higher survival 
rate. We conducted a systematic review of the literature, sear-
ching for the best scientific evidence on the subject. The re-
search was carried out in the following databases: MEDLINE, 
EMBASE, CINAHL and the Cochrane Central Register of ran-
domized controlled trials (CCTR), seeking to identify studies 
that report complications, and compare patellar resurfacing 
versus retention. The studies were selected according to the 
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best methodological quality that exists for the subject. One 
hundred and forty six (146) studies were evaluated. No ran-
domized clinical trial was found. We conducted a qualitative 
and quantitative evaluation of the work found (evidence levels 
IV and V). We used the Mann-Whitney U test for the statistical 
analysis. The results indicate a need for further studies that 
will enable us to reach a more solid conclusion. The rate of 
complications after NCE can be considered high, despite the 
low quality of the studies, as demonstrated by the studies that 
exist in the literature.
Keywords: Bone neoplasms. Knee. Arthroplasty, Replace-
ment, Knee. Osteosarcoma.
introDuction
The use of non-conventional endoprostheses (NCE) for the 
treatment of bone tumors at knee level is a reality of orthopedic 
oncology. The fact that these lesions are frequent in young 
patients with a survival rate above 10 years prompts us to 
determine the best treatment method, especially for articular 
reconstruction of the knee.
The non-conventional endoprosthesis presents advantages in 
relation to the other methods, as it enables the preservation 
of the limb and its articular functions.1-3 It is also a fact that 
preservation of the limb is not associated with reduction of 
the survival rate of the oncological patient.1,2 This makes it 
possible to recommend non-conventional endoprostheses in 
85% of cases.3-5
The questioning of the rate of complications inherent to the 
procedure, including - and especially – those related to the 
function of the extensor mechanism, arises in this scope. This 
is best resolved in a non-oncological population.6,7 Interna-
tional literature describes several complications relating to 
patella replacement, such as patellar component loosening, 
patellar fracture and rupture of the patellar tendon.6,8,9
In the real practice of orthopedic oncology, the approach 
to the topic involves obstacles since surveys focus on sur-
vival, resection size and functional scores of the affected 
limb, which transforms the topic into a field of research and 
exploration.1,2,5,10-12 However, it appears to us to be difficult to 
conduct clinical studies without multicentric collaboration. 
Systematic reviews are a summary of the literature that 
addresses the available data and promotes the acquisition 
of rational information for clinical decisions.13-15 The aim of 
this survey is to promote a systematic review to answer the 
following clinical questions: 1) Which is the rate of post-NCE 
complications? 2) Which is the contribution of patellar com-
plications in this population?
materialS anD methoDS
The following bases in the English, Spanish and Portuguese 
languages were investigated up to June 2009: MEDLINE; 
EMBASE; CINAHL; LILACS and the Cochrane Database 
of Systematic Reviews. The inclusion criteria are set out in 
Chart 1. The strategy of research for randomized clinical 
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chart 1. Basic methodological criteria for inclusion in studies.
1. Study design: Randomized Clinical Trials, observational studies with established final 
outcome – complications (cohorts, case-control, case series);
2. Study design with randomized intervention or different cohorts in follow-up or case 
series with defined complication outcomes;
4. Evaluation of associated criteria of functionality and quality of life;
5. Literature written in Portuguese, English and Spanish;
6. Publication until June 2009.
chart 2. List of Terms used in the search strategy.
1. Knee
2. Osteosarcoma
3. Bone tumors or bone neoplasms
4. Replacement or resurfacing or substitution
5. Total knee replacement
6. Knee Prosthesis or Total knee prosthesis
7. Patella or Patellar
8. Comparative study, random allocation, randomized controlled trials, single blind 
method, double-blind method, controlled clinical trials, clinical trials
9. Endoprosthesis
10. Distal Femur
11. Proximal tibia
12. Arthroplasty
Author, year Site of performance Type of study Sample Follow-up time Relevant outcomes Other information
Bickels, 200219
Washington, USA 
(Washington Cancer Institute, 
Washington Hospital Center) Tel Aviv, 
Israel (Tel-Aviv University)
Case 
series 
110 patients, age 
10-80 years, mean 
age 21.5 years 
Minimum of two 
years, mean time 7.8 
years.
There was no systematized 
intervention 
No routine replacement was 
performed; authors justify 
that they present a young 
sample group
Frink3, 2005 Houston, TX (University of Texas, M.D. Anderson Cancer Center)
Case 
series 
83 patients, 13-77 
years, mean age 25 
years
Mean-146 months 
(62-252 months) 
There was no systematized 
intervention. 
They report 26 
complications, one related 
to the failure of the patellar 
component *
Kawai, 199820 New York, USA (MSKCC) Case series
40 patients, 12-68, 
mean age 25.6 
years
Mean eight years 
(5-17 years)
There was no systematized 
intervention. 
30 complications, two 
patellar fractures*
Schawb, 20068 New York, USA (Weill Medical College of Cornell University)
Case 
series
43 patients, mean 
age 41 years
40 months 
(10-101 months)
There was a comparison of 15 
patients (with substitution) with 28 
(without substitution). There was 
no statistical significance for the 
parameters evaluated ****
The decision to replace the 
patella was made in the 
intraoperative stage ***
* 53 of the patients underwent replacement of the articular component of the patella (polyethylene)** Patellar osteotomy was performed in the intraoperative period in both cases.*** International Society 
Of Limb Salvage (ISOLS) score, range of motion, symptoms in the anterior region of the knee. **** The investigators considered the quality of the articular surface and patellar congruence/morphology in 
relation to the articular surface. 
table 1. Characteristics of the publications included in the analysis.
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trials was used according to the methodology of the Cochra-
ne collaboration.14,16 
A strategy was used to search for non-CCTR publications with 
the use of MeSH/DeCS terms (when available) and non-MeSH/
DeCS terms. The terms used are described in Chart 2. When 
it proved impossible to use a MeSH/DeCS term, non-MESH 
terms were used. After the localization of studies congruent 
with the parameters to be analyzed, each eligible study was 
methodologically evaluated by two investigators (V.Y.M. and 
D.C.V) with inclusion and exclusion based on methodological 
criteria established by known instruments.17,18
reSultS
One hundred forty-six (146) articles were analyzed. No ran-
domized clinical trial was found. No allocation was found in 
different groups for the outcome proposed by this publication, 
both as primary or secondary outcome. Four studies were 
included in the analysis, as they represented the best evi-
dence on the topic foreseen. A study was found referring to 
the topic of interest of this publication, treated as secondary 
outcome and with sample group identified by the authors as 
insufficient.8 The methodological characteristics, as well as 
the descriptive and inferential analysis of these studies, are 
summarized in Tables 1, 2 and 3. 
DiScuSSion
The randomized clinical trials, preferred targets of systema-
tic reviews on therapeutic approaches, have not yet been 
found for the topic in question. In the sphere of orthopedics, 
lengthy discussions have been held on the validity of and 
the need to conduct randomized clinical trials and there is a 
global effort to this end, especially when related to diseases 
of high complexity and of low prevalence, as is the case 
of malignant bone tumors. In this context, the ideal study 
design would be that of a clinical trial (multicentric), which 
would foresee complications as the outcome.19 
In this panorama, the use of the available literature appears 
to us to be evidence that should be valued, especially in 
clinical situations such as those that involve oncological 
populations. Accordingly, the results of this survey should 
serve as a parameter and as a possible tool to guide the 
external validity of probable studies on the subject genera-
ted by other investigators.
As concerns the research methods used for the project, 
we should be mindful of some selection biases. These are 
important biases: the language restriction, the absence of 
the search for unpublished and/or non-indexed surveys 
(example: conference annals). It also proved difficult, on 
certain occasions, to define and characterize outcomes, 
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table 2. Metasynthesis of the studies included – complications
Study, year
Presence of post-NCE 
complications 
Absence of post-NCE 
complications
P value
Frink, 2005 (21)  26 (31.3%) 57 (68.7%)
Kawai,1998(20)  30 (75%) 10 (25%)
Bickels,2002(19) 23 (20.9%) 87 (79.1%)
Sum 79 (33.9%) 154 (66.1%) .000(1)
Mann-Whitney U test
table 3. Metasynthesis of the studies included – patellar complications
Study, year Presence of post-NCE patellar complications
Absence of post-NCE 
patellar complications P value
Frink, 2005(21) 1 (3.8%) 25 (96.2%)
Kawai,1998(20) 2 (6.7%) 28 (93.3%)
Schawb,2006(8) 35 (81.4%) 8 (18.6%)
Sum 38 (38.4%) 61 (61.6 %) .000(1)
(1) Mann-Whitney U test
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which were sometimes scarcely precise and specific, and 
generally treated complications as secondary outcomes. 
The shortage of studies of better methodological quality 
was a barrier to our study. However, the findings that lite-
rature provides us on the subject came as a great surpri-
se. We found several surveys with a low level of evidence 
(evidence level III or IV).1-5,8,10,11,20,21,22-25 This reflects the 
challenge and the difficulty involved in clinical surveys on 
orthopedic oncology. 
concluSion
There is a need for the completion of studies focusing on 
the proposed topic, especially randomized clinical trials, 
in order to arrive at a more solid conclusion with respect 
to patellar replacement in patients with bone tumors in the 
knee. New surveys are necessary to reach conclusions 
on the proposed topic. In spite of the low methodological 
quality, rates of post-NCE complications can be considered 
high in international literature.
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